Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 4 studies | 22% ± 7% | |
glutamatergic neuron | 3 studies | 27% ± 11% | |
interneuron | 3 studies | 39% ± 19% |
Insufficient scRNA-seq data for expression of ADRA1B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 498.41 | 226 / 226 | 78% | 4.30 | 317 / 406 |
ovary | 88% | 224.84 | 159 / 180 | 83% | 7.18 | 356 / 430 |
kidney | 92% | 178.83 | 82 / 89 | 77% | 8.44 | 690 / 901 |
brain | 71% | 245.98 | 1885 / 2642 | 88% | 5.02 | 618 / 705 |
thymus | 76% | 133.15 | 495 / 653 | 82% | 5.40 | 494 / 605 |
adrenal gland | 80% | 139.57 | 207 / 258 | 68% | 4.41 | 157 / 230 |
lung | 90% | 351.21 | 520 / 578 | 33% | 1.21 | 386 / 1155 |
breast | 77% | 161.15 | 352 / 459 | 38% | 1.39 | 422 / 1118 |
skin | 55% | 110.50 | 992 / 1809 | 52% | 2.91 | 246 / 472 |
spleen | 99% | 973.59 | 239 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 903.63 | 1298 / 1335 | 0% | 0 | 0 / 0 |
adipose | 95% | 265.30 | 1141 / 1204 | 0% | 0 | 0 / 0 |
uterus | 59% | 111.95 | 101 / 170 | 24% | 0.86 | 111 / 459 |
heart | 74% | 96.09 | 637 / 861 | 0% | 0 | 0 / 0 |
esophagus | 40% | 48.49 | 577 / 1445 | 19% | 0.57 | 35 / 183 |
intestine | 46% | 51.62 | 441 / 966 | 11% | 0.62 | 57 / 527 |
pancreas | 4% | 2.99 | 14 / 328 | 40% | 1.73 | 71 / 178 |
stomach | 31% | 28.15 | 110 / 359 | 8% | 0.19 | 24 / 286 |
prostate | 30% | 36.72 | 73 / 245 | 7% | 0.10 | 34 / 502 |
tonsil | 0% | 0 | 0 / 0 | 24% | 1.26 | 11 / 45 |
bladder | 14% | 9.71 | 3 / 21 | 10% | 0.53 | 51 / 504 |
lymph node | 0% | 0 | 0 / 0 | 24% | 2.04 | 7 / 29 |
eye | 0% | 0 | 0 / 0 | 16% | 0.26 | 13 / 80 |
muscle | 5% | 4.82 | 44 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.22 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007188 | Biological process | adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
GO_0071880 | Biological process | adenylate cyclase-activating adrenergic receptor signaling pathway |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0019229 | Biological process | regulation of vasoconstriction |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0007267 | Biological process | cell-cell signaling |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_0055117 | Biological process | regulation of cardiac muscle contraction |
GO_0150099 | Biological process | neuron-glial cell signaling |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005901 | Cellular component | caveola |
GO_0005634 | Cellular component | nucleus |
GO_0004937 | Molecular function | alpha1-adrenergic receptor activity |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ADRA1B |
Protein name | Alpha-1B adrenergic receptor (Alpha-1B adrenoreceptor) (Alpha-1B adrenoceptor) Adrenoceptor alpha 1B |
Synonyms | |
Description | FUNCTION: This alpha-adrenergic receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. Its effect is mediated by G(q) and G(11) proteins. Nuclear ADRA1A-ADRA1B heterooligomers regulate phenylephrine (PE)-stimulated ERK signaling in cardiac myocytes. . |
Accessions | A0A286YF88 P35368 ENST00000306675.5 ENST00000641205.1 |